Monday, December 11, 2017 12:20:48 PM
“Company further clarifies that it is in very preliminary stage of exploring avenues and in discussion in synergy between our core activities of pharmaceuticals, cosmeceuticals and nutraceuticals and digital currencies like Bitcoin, Crypto-Currencies, ICO and / or similar products and driving revenues through B2B & B2C channels.”
If you haven't learned yet, most posts on a message board are in the writer's opinion. All of my posts are in my opinion (IMO)......do your Due Diligence (DD) and make up your own mind!
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
